LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer

Li, J; Zhang, Z; Dai, Z; Plass, C; Morrison, C; Wang, Y; Wiest, JS; Anderson, MW; You, M

HERO ID

2215779

Reference Type

Journal Article

Year

2003

Language

English

PMID

12606951

HERO ID 2215779
In Press No
Year 2003
Title LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer
Authors Li, J; Zhang, Z; Dai, Z; Plass, C; Morrison, C; Wang, Y; Wiest, JS; Anderson, MW; You, M
Journal Oncogene
Volume 22
Issue 8
Page Numbers 1243-1246
Abstract Previous observation has shown that the wild-type Kras2 allele is a suppressor of lung cancer in mice. Here we report that loss of heterozygosity (LOH) of chromosome 12p was detected in approximately 50% of human lung adenocarcinomas and large cell carcinomas, and Kras2 mutations were detected at codon 12 in approximately 40% of adenocarcinomas and large cell carcinomas. Interestingly, all of the lung adenocarcinomas and large cell carcinomas containing a Kras2 mutation exhibited allelic loss of the wild-type Kras2 allele when a correlation between LOH of the region on chromosome 12p and Kras2 mutation was made. These results from human lung cancer tissues provide a strong evidence in support of our previous observation in mouse models that the wild-type Kras2 is a tumor suppressor of lung cancer.
Doi 10.1038/sj.onc.1206192
Pmid 12606951
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English